832 related articles for article (PubMed ID: 19469431)
1. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
[TBL] [Abstract][Full Text] [Related]
3. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
[TBL] [Abstract][Full Text] [Related]
4. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine.
Hamkar R; Jalilvand S; Abdolbaghi MH; Esteghamati AR; Hagh-Goo A; Jelyani KN; Mohktari-Azad T; Zahraei M; Nategh R
Vaccine; 2006 Apr; 24(17):3558-63. PubMed ID: 16510217
[TBL] [Abstract][Full Text] [Related]
5. Rubella immune status of pregnant and non-pregnant women in Istanbul, Turkey.
Seker S; Abasiyanik MF; Salih BA
Saudi Med J; 2004 May; 25(5):575-9. PubMed ID: 15138523
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of rubella-IgG antibody in women of childbearing age in Lagos, Nigeria.
Onyenekwe CC; Kehinde-Agbeyangi TA; Ofor US; Arinola OG
West Afr J Med; 2000; 19(1):23-6. PubMed ID: 10821082
[TBL] [Abstract][Full Text] [Related]
7. Rubella vaccination of unknowingly pregnant women during 2006 mass campaign in Argentina.
Pardon F; Vilariño M; Barbero P; Garcia G; Outon E; Gil C; Vera A; Rossi S; Distefano A
J Infect Dis; 2011 Sep; 204 Suppl 2():S745-7. PubMed ID: 21954276
[TBL] [Abstract][Full Text] [Related]
8. Rubella serology in pregnant women attending health centres of Tehran University of Medical Sciences.
Majlessi F; Batebi A; Shariat M; Rahimi A; Azad TM
East Mediterr Health J; 2008; 14(3):590-4. PubMed ID: 18720623
[TBL] [Abstract][Full Text] [Related]
9. [Avidity of rubella IgG antibody in rubella virus infection].
Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1389-93. PubMed ID: 8270822
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
[TBL] [Abstract][Full Text] [Related]
12. Fetal risk associated with rubella vaccination during pregnancy.
Badilla X; Morice A; Avila-Aguero ML; Saenz E; Cerda I; Reef S; Castillo-Solórzano C
Pediatr Infect Dis J; 2007 Sep; 26(9):830-5. PubMed ID: 17721380
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
Minussi L; Mohrdieck R; Bercini M; Ranieri T; Sanseverino MT; Momino W; Callegari-Jacques SM; Schuler-Faccini L
Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcomes following rubella vaccination: a prospective study in the state of Rio de Janeiro, Brazil, 2001-2002.
da Silva e Sá GR; Camacho LA; Stavola MS; Lemos XR; Basílio de Oliveira CA; Siqueira MM
J Infect Dis; 2011 Sep; 204 Suppl 2():S722-8. PubMed ID: 21954273
[TBL] [Abstract][Full Text] [Related]
16. [Simplified avidity assay of rubella IgG antibody in rubella virus infection].
Hoshiba T; Nishimoto H; Asamoto A; Yabuki Y
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Jun; 48(6):413-8. PubMed ID: 8752702
[TBL] [Abstract][Full Text] [Related]
17. Clinical rubella reinfection during pregnancy in a previously vaccinated woman.
Aboudy Y; Barnea B; Yosef L; Frank T; Mendelson E
J Infect; 2000 Sep; 41(2):187-9. PubMed ID: 11023770
[TBL] [Abstract][Full Text] [Related]
18. Significance of avidity and immunoblot analysis for rubella IgM-positive serum samples in pregnant women.
Hofmann J; Liebert UG
J Virol Methods; 2005 Dec; 130(1-2):66-71. PubMed ID: 16024097
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of commercial rubella immunoglobulin G avidity assays.
Mubareka S; Richards H; Gray M; Tipples GA
J Clin Microbiol; 2007 Jan; 45(1):231-3. PubMed ID: 17093027
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey.
Uyar Y; Balci A; Akcali A; Cabar C
New Microbiol; 2008 Oct; 31(4):451-5. PubMed ID: 19123299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
